Coronary Arterial Disease (CAD), Restenosis, Coronary, Bifurcation Coronary Disease
Conditions
Brief summary
Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.
Interventions
DEVICEDEB
Use of DEB to treat coronary lesions
Sponsors
Olivier F. Bertrand
Study design
Observational model
CASE_ONLY
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults (\>=18 years of age) * Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025 * Identified in the institutional procedure database
Exclusion criteria
* Incomplete or non-available data on the post-procedural clinical follow-up * Procedures where other devices were used in combination with drug-eluting balloons.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Major Adverse Cardiovascular Events | within 10 years of inclusion | defined as: * Cardiovascular death * Myocardial infarction * Target vessel revascularization * Cerebrovascular event * Hospitalization due to heart failure |
Countries
Canada
Contacts
Primary ContactMichele Jadin
Outcome results
None listed